Digital Pathology Market

Request for customization Inquire Before Buying

Digital Pathology Market By Product (Scanners, Software, Storage Systems), By Type (Animal, Human Pathology, Veterinary Pathology), By End User (Academic & Research Institutes, Hospitals and Reference Laboratories, Pharmaceutical & Biotechnology Companies), And By Application (Disease Diagnosis, Drug Discovery, Training & Education) - Forecast Year 2024 – 2031

Healthcare // Healthcare IT

Number of Pages: 289 Report Format: pdf Report ID: ZBA-93 Publishing Date: - April, 2022

Frequently Ask Question

The Global Digital Pathology Market Is Forecasted To Grow At A Rate Of 4.7% To USD 57.54 Billion In 2029.

Key Factors That Are Driving The Market Growth Include Growing applications of digital pathology in drug development and companion diagnostics, Increasing adoption of digital pathology to enhance lab efficiency, Rising incidence of cancer

The Digital Pathology Market Is Led By Scanners Segment And Is Projected To Account For The Largest Size Of The Digital Pathology Market From 2022 To 2029.

Some Key Players Operating In The Digital Pathology Market Include 3Dhistech Kft., Aiforia Technologies OY, Akoya Biosciences, Apollo Enterprise Imaging Corp., Corista, Danaher Corporation (Leica Microsystem), F. Hoffmann-La Roche Ltd., Glencoe Software, Inc., Hamamatsu Photonics, Huron Digital Pathology, Indica Labs, Inspirata, Inc., Koninklijke Philips N.V., Leica Biosystems, Nikon Corporation, Objective Pathology Services, Optrascan, Inc., Paige, Perkinelmer Inc., Proscia, Inc., Sectra AB, Visiopharm, XIFIN, Inc.

North America Dominated The Digital Pathology Market In 2021.